CM1 Ligation Induces Apoptosis via Fas-FasL Interaction in Ramos Cells, but via Down-regulation of Bcl-2 and Subsequent Decrease of Mitochondrial Membrane Potential in Raji Cells

  • Lee, Young-Sun (Department of Anatomy and Tumor Immunity Medical Research Center, Seoul National University College of Medicine) ;
  • Kim, Yeong-Seok (Department of Anatomy, Inje University College of Medicine) ;
  • Kim, Dae-Jin (Department of Anatomy and Tumor Immunity Medical Research Center, Seoul National University College of Medicine) ;
  • Hur, Dae-Young (Department of Anatomy, Inje University College of Medicine) ;
  • Kang, Jae-Seung (Department of Anatomy and Tumor Immunity Medical Research Center, Seoul National University College of Medicine) ;
  • Kim, Young-In (Department of Anatomy and Tumor Immunity Medical Research Center, Seoul National University College of Medicine) ;
  • Hahm, Eun-Sil (Department of Anatomy and Tumor Immunity Medical Research Center, Seoul National University College of Medicine) ;
  • Cho, Dae-Ho (Department of Life Science, Sookmyung Women's University) ;
  • Hwang, Young-Il (Department of Anatomy and Tumor Immunity Medical Research Center, Seoul National University College of Medicine) ;
  • Lee, Wang-Jae (Department of Anatomy and Tumor Immunity Medical Research Center, Seoul National University College of Medicine)
  • Published : 2006.06.30

Abstract

Background: CM1 (Centrocyte/-blast Marker I) defined by a mAb developed against concanavalin-A activated PBMC, is expressed specifically on a subpopulation of centroblasts and centrocytes of human germinal center (GC) B cells. Burkitt lymphoma (BL) is a tumor consisting of tumor cells with the characteristics of GC B cell. Previously we reported that CM1 ligation with anti-CM1 mAb induced apoptosis in Ramos $(IgM^{high})$ and Raji $(IgM^{low})$ cells. Methods & Results: In the present study, we observed that CM1 ligation with anti-CM1 mAb induced Fas ligand and Fas expression in Ramos cells, but not in Raji cells. Furthermore, anti-Fas blocking antibody, ZB4, blocked CM1-mediated apoptosis effectively in Ramos cells, but not in Raji cells. Increased mitochondrial membrane permeabilization, which was measured by $DiOC_6$, was observed only in Raji cells. In contrast to no significant change of Bax known as pro-apoptotic protein, anti-apoptotic protein Bcl-2 was significantly decreased in Raji cells. In addition, we observed that CM1 ligation increased release of mitochondrial cytochrome c and upregulated caspase-9 activity in Raji cells. Conclusion: These results suggest that apoptosis induced by CM1-ligation is mediated by Fas-Fas ligand interaction in Ramos cells, whereas apoptosis is mediated by down-regulation of Bcl-2 and subsequent decrease of mitochondrial membrane potential in Raji cells.

Keywords

References

  1. Hur DY, Kim S, Kim YI, Min HY, Kim DJ, Lee DS, Cho D, Hwang YI, Hwang DH, Park SH, Ahn HK, Chang KY, Kim YB, Lee WJ: CM1, a possible novel activation molecule on human lymphocytes. Immunol Lett 74;95-102, 2000 https://doi.org/10.1016/S0165-2478(00)00201-7
  2. Magrath I: The pathogenesis of Burkitt's lymphoma. Adv Cancer Res 55;133-270, 1990 https://doi.org/10.1016/S0065-230X(08)60470-4
  3. Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, Gorden J, Rickinson AB: Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 349;612-614, 1991 https://doi.org/10.1038/349612a0
  4. Baker MP, Eliopoulos AG, Young LS, Armitage RJ, Gregory CD, Gordon J: Prolonged phenotypic, functional, and molecular change in group I burkitt lymphoma cells on short-term expose to CD40 ligand. Blood 92;2830-2843, 1998
  5. Gregory CD, Tursz T, Edwards CF, Tetaud C, Talbot M, Caillou B, Rickinson AB, Lipinski M: Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype. J Immunol 139;313-318, 1987
  6. Kim D, Hur DY, Kim YS, Lee K, Lee Y, Cho D, Kang JS, Kim YI, Hahm E, Yang Y, Yoon S, Kim S, Lee WB, Park HY, Kim YB, Hwang YI, Chang KY, Lee WJ: CM1 ligation initiates apoptosis in a caspase-8-dependent manner in Ramos cells and in a mitochondria-controlled manner in Raji cells. Hum Immunol 63;576-587, 2002 https://doi.org/10.1016/S0198-8859(02)00405-6
  7. van Eijk M, Defrance T, Hennino A, de Groot C: Deathreceptor contribution to the germinal-center reaction. Trends Immunol 22;677-682, 2001 https://doi.org/10.1016/S1471-4906(01)02086-5
  8. McCarthy NJ, Smith CA, Williams GT: Apoptosis in the development of the immune system: growth factors, clonal selection and bcl-2. Cancer Metast Rev 11;157-178, 1992 https://doi.org/10.1007/BF00048062
  9. MacLennan IC: Germinal centers. Annu Rev Immunol 12;117-139, 1994 https://doi.org/10.1146/annurev.iy.12.040194.001001
  10. Guzman-Rojas L, Sims-Mourtada JC, Rangel R, Martinez- Valdez H: Life and death within germinal centres: a doubledged sword. Immunology 107;167-175, 2002 https://doi.org/10.1046/j.1365-2567.2002.01494.x
  11. Nagata S: Apoptosis by death factor. Cell 88;355-365, 1997 https://doi.org/10.1016/S0092-8674(00)81874-7
  12. Wallach D, Boldin M, Varfolomeev E, Beyaert R, Vandenabeele P, Fiers W: Cell death induction by receptors of the TNF family: towards a molecular understanding. FEBS Lett 410;96-106, 1997 https://doi.org/10.1016/S0014-5793(97)00553-X
  13. Stanger BZ, Marshak-Rothstein A: Fas (CD95)/FasL interactions required for programmed cell death after B-cell activation. Nature 373;444-448, 1995 https://doi.org/10.1038/373444a0
  14. Sungkman A, Yap D, Knox KA: Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos- Burkitt lymphoma B cells. Cell Immunol 181;139-152, 1997 https://doi.org/10.1006/cimm.1997.1211
  15. Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH: Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373;438-441, 1995 https://doi.org/10.1038/373438a0
  16. Friesen C, Herr I, Krammer PH, Debatin KM: Involvement of the CD95 receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med 2;574-577, 1996 https://doi.org/10.1038/nm0596-574
  17. Rathmel JC, Cooke MP, Ho WY, Grein J, Townsend SE, Davis MM, Goodnow CC: CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 376;181-184, 1995 https://doi.org/10.1038/376181a0
  18. Moller P, Henne C, Leithauser F, Eichelmann A, Schmidt A, Bruderlein S, Dhein J, Krammer PH: Coregulation of APO-1 antigen with intercellular adhesion molecule-1 (CD54) in tonsillar B cells and coordinate expression in follicular center B cells and in follicle center and mediastinal B-cell lymphomas. Blood 81;2067-2075, 1993
  19. Mami U, Toshiyuki M, Yoshiaki S, Keiko T, Masao Y: Molecular cloning and characterization of six novel isoforms of human Bim, a member of the proapoptotic Bcl-2 family. FEBS Lett 509;135-141, 2001 https://doi.org/10.1016/S0014-5793(01)03145-3
  20. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD: The release of cytochrome c from mitochondria: a primary site for bcl-2 regulation of apoptosis. Science 275;1132-1136, 1997 https://doi.org/10.1126/science.275.5303.1132
  21. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275;1129-1132, 1997 https://doi.org/10.1126/science.275.5303.1129
  22. Yasuhara N, Sahara S, Kamada S, Equchi Y, Tsujimoto Y: Evidence against a functional site for Bcl-2 downstream of caspase cascade in preventing apoptosis. Oncogene 15; 1921-1928, 1997 https://doi.org/10.1038/sj.onc.1201370
  23. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74;609-619, 1993 https://doi.org/10.1016/0092-8674(93)90509-O
  24. Suman P, Tathagata C, Sreya C, Arindam B, Goutam KD, Tanya D, Gaurisankar S: Mechanisms of curcumin-induced apoptosis of Ehrlich's ascites carcinoma cells. Biochem Biophys Res Commun 288;658-665, 2001 https://doi.org/10.1006/bbrc.2001.5823
  25. Cassarino DS, Parks JK, Parker WD, Bennett, JP: The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and release cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim Biophys Acta 1453;49-62, 1999 https://doi.org/10.1016/S0925-4439(98)00083-0
  26. Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, Crowe RA, Cascio WE, Bradham CA, Brenner DA, Herman B: The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1366;177-196, 1998 https://doi.org/10.1016/S0005-2728(98)00112-1
  27. Montine TJ, Markesbery WR, Zackert W, Sanchez SC, Roberts LJ, Morrow JD: The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients. Am J Pathol 155;863-868, 1999 https://doi.org/10.1016/S0002-9440(10)65185-1
  28. Morita-Fujimura Y, Fujimura M, Kawase M, Chen SF, Chan PH: Release of mitochondrial cytochrome c and DNA fragmentation after cold injury-induced brain trauma in mice: possible role in neuronal apoptosis. Neurosci Lett 267; 201-205, 1999 https://doi.org/10.1016/S0304-3940(99)00327-4
  29. Othman G, David AD, Michael SF, Mary MH, John S: Coinvolvement of mitochondria and endoplasmic reticulum in regulation of apoptosis: changes in cytochrome c, Bcl-2 and Bax in the hippocampus of aluminum-treated rabbits. Brain Research 903;66-73, 2001 https://doi.org/10.1016/S0006-8993(01)02406-4
  30. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91;479-489, 1997 https://doi.org/10.1016/S0092-8674(00)80434-1
  31. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Alnemri ES: Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol Cell 1;949-957, 1998 https://doi.org/10.1016/S1097-2765(00)80095-7
  32. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere JL, Petit PX, Kroemer G: Reduction in mitochondria potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 181;1661-1672, 1995 https://doi.org/10.1084/jem.181.5.1661
  33. Jeffrey AH, Michele B, Bruce M, Bleackley RC: Granzyme B-induced loss of mitochondria inner membrane potential($\Delta$ $\Psi_m$) and cytochrome c release are caspase independent. J Immunol 163;4683-4693, 1999
  34. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Alnemri ES: Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol Cell 1;949-957, 1998 https://doi.org/10.1016/S1097-2765(00)80095-7
  35. Maria P, Montserrat B, Mireia D, Beatriz B, Gabriel P, Joan G: Aspirin induces apoptosis through mitochondrial cytochrome c release. FEBS Lett 480;193-196, 2000 https://doi.org/10.1016/S0014-5793(00)01922-0
  36. Tsujimoto Y, Cossman J, Jaffe E, Croce CM: Involvement of the bcl-2 gene in human follicular lymphoma. Science 228;1440-1443, 1985 https://doi.org/10.1126/science.3874430
  37. Vaux D, Cory S, Adams J: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335;440-442, 1988 https://doi.org/10.1038/335440a0
  38. Monaghan P, Robertson D, Amos TAS, Dyer MJS, mason DY, Greaves MF: Ultrastructural localization of Bcl-2 protein. J Histochem Cytochem 40;1819-1825, 1992 https://doi.org/10.1177/40.12.1453000
  39. Jacobson MD, Burnett JF, King MD, Miyashita T, Reed JC, Raff MC: Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361;365-369, 1993 https://doi.org/10.1038/361365a0
  40. Hideshi Y, Yasuo N, Kachio T: IFN-${\gamma}$ induces the apoptosis of WEHI 279 and normal Pre-B cell lines by expressing direct inhibitor of apoptosis protein binding protein with low pI. J Immunol 167;2487-2495, 2001 https://doi.org/10.4049/jimmunol.167.5.2487